LGALS3 and hydrops fetalis: Lorenzo-Almorós et al. revealed that, in patients with STEMI or NSTEMI, Gal-3 concentrations above 6.49 ng/mL were associated with an increased risk of MACE defined as acute ischaemic events, HF, or death (HR 3.26 (95% CI: 1.32–8.04); p = 0.010) during a 5.6-year follow-up [31].